Literature DB >> 26479498

One gene but different proteins and diseases: the complexity of dystonin and bullous pemphigoid antigen 1.

Kseniia Künzli1, Bertrand Favre1, Michel Chofflon2, Luca Borradori1.   

Abstract

Since the immunochemical identification of the bullous pemphigoid antigen 230 (BP230) as one of the major target autoantigens of bullous pemphigoid (BP) in 1981, our understanding of this protein has significantly increased. Cloning of its gene, development and characterization of animal models with engineered gene mutations or spontaneous mouse mutations have revealed an unexpected complexity of the gene encoding BP230. The latter, now called dystonin (DST), is composed of at least 100 exons and gives rise to three major isoforms, an epithelial, a neuronal and a muscular isoform, named BPAG1e (corresponding to the original BP230), BPAG1a and BPAG1b, respectively. The various BPAG1 isoforms play a key role in fundamental processes, such as cell adhesion, cytoskeleton organization, and cell migration. Genetic defects of BPAG1 isoforms are the culprits of epidermolysis bullosa and complex, devastating neurological diseases. In this review, we summarize recent advances of our knowledge about several BPAG1 isoforms, their role in various biological processes and in human diseases.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BP230; BPAG1; Dystonia musculorum; bullous pemphigoid; dystonin; epidermolysis bullosa simplex; neurological disease; plakin; sensory autonomic neuropathy

Mesh:

Substances:

Year:  2015        PMID: 26479498     DOI: 10.1111/exd.12877

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  20 in total

Review 1.  Spectraplakin family proteins - cytoskeletal crosslinkers with versatile roles.

Authors:  Jamie Zhang; Jiping Yue; Xiaoyang Wu
Journal:  J Cell Sci       Date:  2017-07-05       Impact factor: 5.285

2.  Demographics and Autoantibody Profiles of Pemphigoid Patients with Underlying Neurologic Diseases.

Authors:  Kelly N Messingham; Adam D Miller; Nandakumar S Narayanan; Samuel J Connell; Janet A Fairley
Journal:  J Invest Dermatol       Date:  2019-03-12       Impact factor: 8.551

3.  Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.

Authors:  Kathryn T Bieging-Rolett; Alyssa M Kaiser; David W Morgens; Anthony M Boutelle; Jose A Seoane; Eric L Van Nostrand; Changyu Zhu; Shauna L Houlihan; Stephano S Mello; Brian A Yee; Jacob McClendon; Sarah E Pierce; Ian P Winters; Mengxiong Wang; Andrew J Connolly; Scott W Lowe; Christina Curtis; Gene W Yeo; Monte M Winslow; Michael C Bassik; Laura D Attardi
Journal:  Mol Cell       Date:  2020-11-05       Impact factor: 17.970

4.  Novel mutations in dystonin provide clues to the pathomechanisms of HSAN-VI.

Authors:  Fiore Manganelli; Silvia Parisi; Maria Nolano; Feifei Tao; Simona Paladino; Chiara Pisciotta; Stefano Tozza; Claudia Nesti; Adriana P Rebelo; Vincenzo Provitera; Filippo M Santorelli; Michael E Shy; Tommaso Russo; Stephan Zuchner; Lucio Santoro
Journal:  Neurology       Date:  2017-05-03       Impact factor: 9.910

5.  Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study.

Authors:  Anna-Kaisa Försti; Jari Jokelainen; Hanna Ansakorpi; Allan Seppänen; Kari Majamaa; Markku Timonen; Kaisa Tasanen
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

Review 6.  Defenders and Challengers of Endothelial Barrier Function.

Authors:  Nader Rahimi
Journal:  Front Immunol       Date:  2017-12-18       Impact factor: 7.561

7.  Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson's disease is more relevant to bullous pemphigoid.

Authors:  Paweł Bartkiewicz; Justyna Gornowicz-Porowska; Paweł P Pietkiewicz; Anna Świrkowicz; Monika Bowszyc-Dmochowska; Marian Dmochowski
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

Review 8.  Advances in understanding the molecular basis of skin fragility.

Authors:  Cristina Has
Journal:  F1000Res       Date:  2018-03-06

9.  Genetic mapping and phenotypic analysis of shotH.3.2 in Drosophila melanogaster.

Authors:  Elyse M Talley; Charlie T Watts; Sonia Aboyer; Madeline G Adamson; Harriet Ab Akoto; Haley Altemus; Philip J Avella; Rebecca Bailey; Elizabeth R Bell; Katheryn L Bell; Kelsey Breneman; Jessica S Burkhart; Logan J Chanley; Savannah S Cook; Mackenzie T DesLaurier; Timothy R Dorsey; Cassandra J Doyle; Merris E Egloff; Ayoola S Fasawe; Katy K Garcia; Nathaniel P Graves; Tyler K Gray; Evan M Gustafson; Makayla J Hall; Jaden D Hayes; Lindsay J Holic; Brice A Jarvis; Piotr S Klos; Sidney Kritzmire; Lera Kuzovko; Edwyna Lainez; Shamerra McCoy; James C Mierendorf; Nicole A Neri; Caley R Neville; Kelley Osborn; Kaitlyn Parker; Megan E Parks; Kylee Peck; Robyn Pitt; Matthew E Platta; Brianna Powell; Katalina Rodriguez; Clara Ruiz; Mariah N Schaefer; Amanda B Shields; Jasmine B Smiley; Briona Stauffer; Devan Straub; John L Sweeney; Kaitlyn M Termine; Brett Thomas; Sophia D Toth; Taylor R Veile; Kayla S Walker; Paige N Webster; Brian J Woodard; Quentin L Yoder; McKenzie K Young; McKenzie L Zeedyk; Logan N Ziegler; Kayla L Bieser; David P Puthoff; Joyce Stamm; Alysia D Vrailas-Mortimer; Jacob D Kagey; Julie A Merkle
Journal:  MicroPubl Biol       Date:  2021-07-13

Review 10.  Mammalian Plakins, Giant Cytolinkers: Versatile Biological Functions and Roles in Cancer.

Authors:  Lifang Hu; Zizhan Huang; Zixiang Wu; Arshad Ali; Airong Qian
Journal:  Int J Mol Sci       Date:  2018-03-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.